Tony Godfrey | Profiles RNS

Tony E. Godfrey, PhD

Professor

Boston University Chobanian & Avedisian School of Medicine

Surgery

Other Surgery

PhD, Brunel University
BSc, Brunel University

Websites

	Surgery Faculty
	ResearchGate
	LinkedIn

ORCID : 0000-0002-3283-6983

Tony E. Godfrey, PhD, Associate Chair, Surgical Research and Associate Professor of Surgery, Chobanian and Avedisian School of Medicine, earned a bachelor’s of science degree in biochemistry from Brunel University in England, followed by a doctorate in molecular biology and biochemistry, also from Brunel. He attended the University of California, San Francisco, for postdoctoral fellowships and managed UCSF’s Genome Analysis Core Facility.

Most recently, Dr. Godfrey was a Research Associate Professor in the Department of Surgery at the University of Rochester Medical Center in Rochester, NY. Prior to this he was an Associate Professor of Pathology at Mt. Sinai School of Medicine in New York, NY.

Dr. Godfrey’s research is focused on cancer genetics and molecular pathology. Research projects use state-of-the-art genetic and genomic approaches to address clinical needs in the areas of cancer diagnosis, prognosis and therapy. Currently the major focus of Dr. Godfrey’s research is on Barrett’s esophagus and esophageal adenocarcinoma; a tumor with rapidly increasing incidence in the United States and other western countries. The Godfrey lab works closely with translational research teams comprised of surgeons, pathologists and oncologists in order to develop new molecular approaches to cancer detection, staging and treatment.

Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Computational Biomedicine

Member
Boston University
BU-BMC Cancer Center

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research

Member
Boston University
Genome Science Institute

BU Research
NIH RePORTER Research

Impact of Biological, Clinical, and Social Determinants on Trauma and Trauma Outcomes
07/01/2022 - 06/30/2027 (Multi-PI)
PI: Tony E. Godfrey, PhD
NIH/National Institute of General Medical Sciences
5T32GM086308-12

Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq
06/10/2019 - 08/31/2023 (Subcontract PI)
Fluent BioSciences Inc. NIH NCI
4R44CA244049-03

Development of diagnostic and prognostic tests for esophageal adenocarcinoma
12/16/2016 - 08/31/2023 (PI)
NIH/National Cancer Institute
5R01CA208599-06

Immunobiology of Trauma
07/01/2017 - 06/30/2022 (Multi-PI)
PI: Tony E. Godfrey, PhD
NIH/National Institute of General Medical Sciences
5T32GM086308-10

Feasibility of Molecular Cytology for the Management of Barrett's Esophagus
04/21/2015 - 03/31/2018 (PI)
NIH/National Cancer Institute
5R21CA187753-02

Biomarkers for Esophageal Cancer progression and prognosis
04/01/2013 - 03/31/2018 (Subcontract PI)
Ontario Institute for Cancer Research Genome Canada

Evaluating the Feasibility of a Molecular Cytology Approach for Management of Patients with Barrett's Esophagus
01/15/2014 - 06/30/2016 (PI)
DeGregorio Foundation

Innovative Approach to Cancer Detection and Treatment Monitoring
04/01/2013 - 03/31/2016 (PI)
NIH/National Cancer Institute
5R21CA172999-02

Biomarkers for Esophageal Cancer progression and prognosis
01/01/2013 - 07/31/2015 (PI)
NIH/National Cancer Institute
7R01CA130853-06

Title

Yr	Title	Project-Sub Proj	Pubs
2022	Development of diagnostic and prognostic tests for esophageal adenocarcinoma	5R01CA208599-06
2022	Impact of Biological, Clinical, and Social Determinants on Trauma and Trauma Outcomes	2T32GM086308-11
2021	Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq	5R44CA244049-03
2021	Development of diagnostic and prognostic tests for esophageal adenocarcinoma	5R01CA208599-05	6
2021	Immunobiology of Trauma	5T32GM086308-10	45
2020	Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq	4R44CA244049-02
2020	Development of diagnostic and prognostic tests for esophageal adenocarcinoma	5R01CA208599-04	6
2019	Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq	1R44CA244049-01
2019	Development of diagnostic and prognostic tests for esophageal adenocarcinoma	5R01CA208599-03	6
2018	Development of diagnostic and prognostic tests for esophageal adenocarcinoma	5R01CA208599-02	6

Showing 10 of 35 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Godfrey TE, Litle VR. Commentary: For thoracic surgeons, a strategic approach to the funding game. J Thorac Cardiovasc Surg. 2022 03; 163(3):881-882.View Related Profiles.

Godfrey, Tony
Litle, Virginia

PMID: 33812681

Johansson G, Andersson D, Filges S, Li J, Muth A, Godfrey TE, Ståhlberg A. Corrigendum to "Considerations and quality controls when analyzing cell-free tumor DNA" [Biomol. Detect. Quantif. 17 (2019) 100078]. Biomol Detect Quantif. 2019 Mar; 17:100091. PMID: 31249790; PMCID: PMC6587021; DOI: 10.1016/j.bdq.2019.100091;

Pennathur A, Godfrey TE, Luketich JD. The Molecular Biologic Basis of Esophageal and Gastric Cancers. Surg Clin North Am. 2019 Jun; 99(3):403-418. PMID: 31047032

Zhou Z, Kalatskaya I, Russell D, Marcon N, Cirocco M, Krzyzanowski PM, Streutker C, Liang H, Litle VR, Godfrey TE, Stein L. Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma. Clin Exp Gastroenterol. 2019; 12:219-229.View Related Profiles.

Godfrey, Tony
Litle, Virginia

PMID: 31190949; PMCID: PMC6527096; DOI: 10.2147/CEG.S186958;

Egyud M, Tejani M, Pennathur A, Luketich J, Sridhar P, Yamada E, Ståhlberg A, Filges S, Krzyzanowski P, Jackson J, Kalatskaya I, Jiao W, Nielsen G, Zhou Z, Litle V, Stein L, Godfrey T. Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal Adenocarcinoma. Ann Thorac Surg. 2019 08; 108(2):343-349.View Related Profiles.

Godfrey, Tony
Litle, Virginia

PMID: 31059681; PMCID: PMC6676214; DOI: 10.1016/j.athoracsur.2019.04.004;

He HJ, Stein EV, Konigshofer Y, Forbes T, Tomson FL, Garlick R, Yamada E, Godfrey T, Abe T, Tamura K, Borges M, Goggins M, Elmore S, Gulley ML, Larson JL, Ringel L, Haynes BC, Karlovich C, Williams PM, Garnett A, Ståhlberg A, Filges S, Sorbara L, Young MR, Srivastava S, Cole KD. Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements. J Mol Diagn. 2019 07; 21(4):658-676. PMID: 31055023; PMCID: PMC6626992; DOI: 10.1016/j.jmoldx.2019.03.006;

Filges S, Yamada E, Ståhlberg A, Godfrey TE. Impact of Polymerase Fidelity on Background Error Rates in Next-Generation Sequencing with Unique Molecular Identifiers/Barcodes. Sci Rep. 2019 03 05; 9(1):3503. PMID: 30837525; PMCID: PMC6401092; DOI: 10.1038/s41598-019-39762-6;

Johansson G, Andersson D, Filges S, Li J, Muth A, Godfrey TE, Ståhlberg A. Considerations and quality controls when analyzing cell-free tumor DNA. Biomol Detect Quantif. 2019 Mar; 17:100078. PMID: 30906693; PMCID: PMC6416156; DOI: 10.1016/j.bdq.2018.12.003;

Egyud M, Sridhar P, Devaiah A, Yamada E, Saunders S, Ståhlberg A, Filges S, Krzyzanowski PM, Kalatskaya I, Jiao W, Stein LD, Jalisi S, Godfrey TE. Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer. Head Neck. 2019 05; 41(5):1351-1358.View Related Profiles.

Devaiah, Anand
Godfrey, Tony

PMID: 30554450; PMCID: PMC6467749; DOI: 10.1002/hed.25563;

Muñoz-Largacha JA, Gower AC, Sridhar P, Deshpande A, O'Hara CJ, Yamada E, Godfrey TE, Fernando HC, Litle VR. miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma. J Thorac Cardiovasc Surg. 2017 08; 154(2):714-727.View Related Profiles.

Gower, Adam
O'Hara, Carl
Godfrey, Tony
Litle, Virginia

PMID: 28495058

Showing 10 of 85 results. Show More

Ståhlberg A, Krzyzanowski PM, Egyud M, Filges S, Stein L, Godfrey TE. Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing. Nat Protoc. 2017 Apr; 12(4):664-682. PMID: 28253235; DOI: 10.1038/nprot.2017.006;

Pang C, LaLonde A, Godfrey TE, Que J, Sun J, Wu TT, Zhou Z. Bile salt receptor TGR5 is highly expressed in esophageal adenocarcinoma and precancerous lesions with significantly worse overall survival and gender differences. Clin Exp Gastroenterol. 2017; 10:29-37. PMID: 28223834; PMCID: PMC5304980; DOI: 10.2147/CEG.S117842;

Ståhlberg A, Krzyzanowski PM, Jackson JB, Egyud M, Stein L, Godfrey TE. Simple, multiplexed, PCR-based barcoding of DNA enables sensitive mutation detection in liquid biopsies using sequencing. Nucleic Acids Res. 2016 Jun 20; 44(11):e105. PMID: 27060140; PMCID: PMC4914102; DOI: 10.1093/nar/gkw224;

Jackson JB, Choi DS, Luketich JD, Pennathur A, Ståhlberg A, Godfrey TE. Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR. J Mol Diagn. 2016 Mar; 18(2):235-43. PMID: 26752305; PMCID: PMC4851734; DOI: 10.1016/j.jmoldx.2015.10.004;

Ghatak S, Reveiller M, Toia L, Ivanov AI, Zhou Z, Redmond EM, Godfrey TE, Peters JH. Bile Salts at Low pH Cause Dilation of Intercellular Spaces in In Vitro Stratified Primary Esophageal Cells, Possibly by Modulating Wnt Signaling. J Gastrointest Surg. 2016 Mar; 20(3):500-9. PMID: 26715559; PMCID: PMC7202037; DOI: 10.1007/s11605-015-3062-2;

Andersson D, Akrap N, Svec D, Godfrey TE, Kubista M, Landberg G, Ståhlberg A. Properties of targeted preamplification in DNA and cDNA quantification. Expert Rev Mol Diagn. 2015; 15(8):1085-100. PMID: 26132215; PMCID: PMC4673511; DOI: 10.1586/14737159.2015.1057124;

Bandla S, Peters JH, Ruff D, Chen SM, Li CY, Song K, Thoms K, Litle VR, Watson T, Chapurin N, Lada M, Pennathur A, Luketich JD, Peterson D, Dulak A, Lin L, Bass A, Beer DG, Godfrey TE, Zhou Z. Comparison of cancer-associated genetic abnormalities in columnar-lined esophagus tissues with and without goblet cells. Ann Surg. 2014 Jul; 260(1):72-80.View Related Profiles.

Godfrey, Tony
Litle, Virginia

PMID: 24509200; PMCID: PMC4047149; DOI: 10.1097/SLA.0000000000000424;

Zhou Z, Xia Y, Bandla S, Zakharov V, Wu S, Peters J, Godfrey TE, Sun J. Vitamin D receptor is highly expressed in precancerous lesions and esophageal adenocarcinoma with significant sex difference. Hum Pathol. 2014 Aug; 45(8):1744-51. PMID: 24951052; DOI: 10.1016/j.humpath.2014.02.029;

Zhou Z, Bandla S, Ye J, Xia Y, Que J, Luketich JD, Pennathur A, Peters JH, Tan D, Godfrey TE. Cyclin E involved in early stage carcinogenesis of esophageal adenocarcinoma by SNP DNA microarray and immunohistochemical studies. BMC Gastroenterol. 2014; 14:78. PMID: 24742107; PMCID: PMC3998234; DOI: 10.1186/1471-230X-14-78;

Ghatak S, Reveiller M, Toia L, Ivanov A, Godfrey TE, Peters JH. Bile acid at low pH reduces squamous differentiation and activates EGFR signaling in esophageal squamous cells in 3-D culture. J Gastrointest Surg. 2013 Oct; 17(10):1723-31. PMID: 23921815; DOI: 10.1007/s11605-013-2287-1;

Trivedi S, Mattos J, Gooding W, Godfrey TE, Ferris RL. Correlation of tumor marker expression with nodal disease burden in metastatic head and neck cancer. Otolaryngol Head Neck Surg. 2013 Aug; 149(2):261-8. PMID: 23625795; PMCID: PMC7721557; DOI: 10.1177/0194599813486876;

Dulak AM, Stojanov P, Peng S, Lawrence MS, Fox C, Stewart C, Bandla S, Imamura Y, Schumacher SE, Shefler E, McKenna A, Carter SL, Cibulskis K, Sivachenko A, Saksena G, Voet D, Ramos AH, Auclair D, Thompson K, Sougnez C, Onofrio RC, Guiducci C, Beroukhim R, Zhou Z, Lin L, Lin J, Reddy R, Chang A, Landrenau R, Pennathur A, Ogino S, Luketich JD, Golub TR, Gabriel SB, Lander ES, Beer DG, Godfrey TE, Getz G, Bass AJ. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet. 2013 May; 45(5):478-86. PMID: 23525077; PMCID: PMC3678719; DOI: 10.1038/ng.2591;

Pennathur A, Xi L, Litle VR, Gooding WE, Krasinskas A, Landreneau RJ, Godfrey TE, Luketich JD. Gene expression profiles in esophageal adenocarcinoma predict survival after resection. J Thorac Cardiovasc Surg. 2013 Feb; 145(2):505-12; discussion 512-3.View Related Profiles.

Godfrey, Tony
Litle, Virginia

PMID: 23321130; DOI: 10.1016/j.jtcvs.2012.10.031;

Choy B, Bandla S, Xia Y, Tan D, Pennathur A, Luketich JD, Godfrey TE, Peters JH, Sun J, Zhou Z. Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma. BMC Gastroenterol. 2012; 12:146. PMID: 23078618; PMCID: PMC3544684; DOI: 10.1186/1471-230X-12-146;

Dulak AM, Schumacher SE, van Lieshout J, Imamura Y, Fox C, Shim B, Ramos AH, Saksena G, Baca SC, Baselga J, Tabernero J, Barretina J, Enzinger PC, Corso G, Roviello F, Lin L, Bandla S, Luketich JD, Pennathur A, Meyerson M, Ogino S, Shivdasani RA, Beer DG, Godfrey TE, Beroukhim R, Bass AJ. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res. 2012 Sep 1; 72(17):4383-93. PMID: 22751462; PMCID: PMC3432726; DOI: 10.1158/0008-5472.CAN-11-3893;

Reveiller M, Ghatak S, Toia L, Kalatskaya I, Stein L, D'Souza M, Zhou Z, Bandla S, Gooding WE, Godfrey TE, Peters JH. Bile exposure inhibits expression of squamous differentiation genes in human esophageal epithelial cells. Ann Surg. 2012 Jun; 255(6):1113-20. PMID: 22498892; DOI: 10.1097/SLA.0b013e3182512af9;

Bandla S, Pennathur A, Luketich JD, Beer DG, Lin L, Bass AJ, Godfrey TE, Litle VR. Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma. Ann Thorac Surg. 2012 Apr; 93(4):1101-6.View Related Profiles.

Godfrey, Tony
Litle, Virginia

PMID: 22450065; PMCID: PMC3401935; DOI: 10.1016/j.athoracsur.2012.01.064;

Ferris RL, Stefanika P, Xi L, Gooding W, Seethala RR, Godfrey TE. Rapid molecular detection of metastatic head and neck squamous cell carcinoma as an intraoperative adjunct to sentinel lymph node biopsy. Laryngoscope. 2012 May; 122(5):1020-30. PMID: 22447185; PMCID: PMC3418874; DOI: 10.1002/lary.22467;

Barry CT, D'Souza M, McCall M, Safadjou S, Ryan C, Kashyap R, Marroquin C, Orloff M, Almudevar A, Godfrey TE. Micro RNA expression profiles as adjunctive data to assess the risk of hepatocellular carcinoma recurrence after liver transplantation. Am J Transplant. 2012 Feb; 12(2):428-37. PMID: 22008552; DOI: 10.1111/j.1600-6143.2011.03788.x;

Ismail A, Bandla S, Reveiller M, Toia L, Zhou Z, Gooding WE, Kalatskaya I, Stein L, D'Souza M, Litle VR, Peters JH, Pennathur A, Luketich JD, Godfrey TE. Early G1 cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma. Clin Cancer Res. 2011 Jul 1; 17(13):4513-22.View Related Profiles.

Godfrey, Tony
Litle, Virginia

PMID: 21593195; PMCID: PMC3390776; DOI: 10.1158/1078-0432.CCR-11-0244;

Hu Y, Bandla S, Godfrey TE, Tan D, Luketich JD, Pennathur A, Qiu X, Hicks DG, Peters JH, Zhou Z. HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma. Mod Pathol. 2011 Jul; 24(7):899-907. PMID: 21460800; PMCID: PMC3138485; DOI: 10.1038/modpathol.2011.47;

Feber A, Xi L, Pennathur A, Gooding WE, Bandla S, Wu M, Luketich JD, Godfrey TE, Litle VR. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann Thorac Surg. 2011 May; 91(5):1523-30.View Related Profiles.

Godfrey, Tony
Litle, Virginia

PMID: 21420070; PMCID: PMC3399250; DOI: 10.1016/j.athoracsur.2011.01.056;

Ferris RL, Xi L, Seethala RR, Chan J, Desai S, Hoch B, Gooding W, Godfrey TE. Intraoperative qRT-PCR for detection of lymph node metastasis in head and neck cancer. Clin Cancer Res. 2011 Apr 1; 17(7):1858-66. PMID: 21355082; PMCID: PMC5270507; DOI: 10.1158/1078-0432.CCR-10-3110;

Filho PA, López-Albaitero A, Xi L, Gooding W, Godfrey T, Ferris RL. Quantitative expression and immunogenicity of MAGE-3 and -6 in upper aerodigestive tract cancer. Int J Cancer. 2009 Oct 15; 125(8):1912-20. PMID: 19610063; PMCID: PMC2757316; DOI: 10.1002/ijc.24590;

Hughes SJ, Xi L, Gooding WE, Cole DJ, Mitas M, Metcalf J, Bhargava R, Dabbs D, Ching J, Kozma L, McMillan W, Godfrey TE. A quantitative reverse transcription-PCR assay for rapid, automated analysis of breast cancer sentinel lymph nodes. J Mol Diagn. 2009 Nov; 11(6):576-82. PMID: 19797614; PMCID: PMC2765757; DOI: 10.2353/jmoldx.2009.090037;

Gupta VK, Feber A, Xi L, Pennathur A, Wu M, Luketich JD, Godfrey TE. Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma. Clin Cancer Res. 2008 Dec 1; 14(23):7804-12. PMID: 19047108; PMCID: PMC2723959; DOI: 10.1158/1078-0432.CCR-08-0744;

Hilari JM, Mangas C, Xi L, Paradelo C, Ferrándiz C, Hughes SJ, Yueh C, Altomare I, Gooding WE, Godfrey TE. Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR. Ann Surg Oncol. 2009 Jan; 16(1):177-85. PMID: 18982394; DOI: 10.1245/s10434-008-0183-9;

Xi L, Feber A, Gupta V, Wu M, Bergemann AD, Landreneau RJ, Litle VR, Pennathur A, Luketich JD, Godfrey TE. Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res. 2008 Nov; 36(20):6535-47.View Related Profiles.

Godfrey, Tony
Litle, Virginia

PMID: 18927117; PMCID: PMC2582617; DOI: 10.1093/nar/gkn697;

Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, Swanson SJ, Godfrey TE, Litle VR. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg. 2008 Feb; 135(2):255-60; discussion 260.View Related Profiles.

Godfrey, Tony
Litle, Virginia

PMID: 18242245; PMCID: PMC2265073; DOI: 10.1016/j.jtcvs.2007.08.055;

Nicastri DG, Doucette JT, Godfrey TE, Hughes SJ. Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn. 2007 Nov; 9(5):563-71. PMID: 17916603; PMCID: PMC2049052; DOI: 10.2353/jmoldx.2007.070032;

Xi L, Nicastri DG, El-Hefnawy T, Hughes SJ, Luketich JD, Godfrey TE. Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. Clin Chem. 2007 Jul; 53(7):1206-15. PMID: 17525108

Huang X, Godfrey TE, Gooding WE, McCarty KS, Gollin SM. Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer. 2006 Nov; 45(11):1058-69. PMID: 16906560

Xi L, Coello MC, Litle VR, Raja S, Gooding WE, Yousem SA, El-Hefnawy T, Landreneau RJ, Luketich JD, Godfrey TE. A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients. Clin Cancer Res. 2006 Apr 15; 12(8):2484-91.View Related Profiles.

Godfrey, Tony
Litle, Virginia

PMID: 16638856; PMCID: PMC1933488; DOI: 10.1158/1078-0432.CCR-05-2037;

Hughes SJ, Xi L, Raja S, Gooding W, Cole DJ, Gillanders WE, Mikhitarian K, McCarty K, Silver S, Ching J, McMillan W, Luketich JD, Godfrey TE. A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg. 2006 Mar; 243(3):389-98. PMID: 16495705; PMCID: PMC1448944; DOI: 10.1097/01.sla.0000201541.68577.6a;

Xi L, Gooding W, McCarty K, Godfrey TE, Hughes SJ. Identification of mRNA markers for molecular staging of lymph nodes in colorectal cancer. Clin Chem. 2006 Mar; 52(3):520-3. PMID: 16510433

Khalid A, Finkelstein S, Thompson B, Kelly L, Hanck C, Godfrey TE, Whitcomb DC. A 93 year old man with the PRSS1 R122H mutation, low SPINK1 expression, and no pancreatitis: insights into phenotypic non-penetrance. Gut. 2006 May; 55(5):728-31. PMID: 16354799; PMCID: PMC1856140; DOI: 10.1136/gut.2005.067959;

Nakajima H, Uchida K, Kobayashi S, Kokubo Y, Yayama T, Sato R, Inukai T, Godfrey T, Baba H. Cervical angina: a seemingly still neglected symptom of cervical spine disorder? Spinal Cord. 2006 Aug; 44(8):509-13. PMID: 16331305

Kuss I, Schaefer C, Godfrey TE, Ferris RL, Harris JM, Gooding W, Whiteside TL. Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancer. Clin Immunol. 2005 Jul; 116(1):27-36. PMID: 15925829

Xi L, Lyons-Weiler J, Coello MC, Huang X, Gooding WE, Luketich JD, Godfrey TE. Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas. Clin Cancer Res. 2005 Jun 1; 11(11):4128-35. PMID: 15930348; PMCID: PMC2211271; DOI: 10.1158/1078-0432.CCR-04-2525;

Ferris RL, Xi L, Raja S, Hunt JL, Wang J, Gooding WE, Kelly L, Ching J, Luketich JD, Godfrey TE. Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res. 2005 Mar 15; 65(6):2147-56. PMID: 15781625

Raja S, Ching J, Xi L, Hughes SJ, Chang R, Wong W, McMillan W, Gooding WE, McCarty KS, Chestney M, Luketich JD, Godfrey TE. Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin Chem. 2005 May; 51(5):882-90. PMID: 15746302

Lotze MT, Wang E, Marincola FM, Hanna N, Bugelski PJ, Burns CA, Coukos G, Damle N, Godfrey TE, Howell WM, Panelli MC, Perricone MA, Petricoin EF, Sauter G, Scheibenbogen C, Shivers SC, Taylor DL, Weinstein JN, Whiteside TL. Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health. J Immunother. 2005 Mar-Apr; 28(2):79-119. PMID: 15725954

Xi L, Luketich JD, Raja S, Gooding WE, Litle VR, Coello MC, Finkelstein SD, Chestney ML, Landreneau RJ, Hughes SJ, Godfrey TE. Molecular staging of lymph nodes from patients with esophageal adenocarcinoma. Clin Cancer Res. 2005 Feb 1; 11(3):1099-109.View Related Profiles.

Godfrey, Tony
Litle, Virginia

PMID: 15709177

Godfrey TE, Kelly LA. Development of quantitative reverse transcriptase PCR assays for measuring gene expression. Methods Mol Biol. 2005; 291:423-45. PMID: 15502240

Wang J, Xi L, Gooding W, Godfrey TE, Ferris RL. Chemokine receptors 6 and 7 identify a metastatic expression pattern in squamous cell carcinoma of the head and neck. Adv Otorhinolaryngol. 2005; 62:121-33. PMID: 15608423

Herrera LJ, El-Hefnawy T, Queiroz de Oliveira PE, Raja S, Finkelstein S, Gooding W, Luketich JD, Godfrey TE, Hughes SJ. The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma. Neoplasia. 2005 Jan; 7(1):75-84. PMID: 15720819; PMCID: PMC1490312; DOI: 10.1593/neo.04367;

Herrera LJ, Raja S, Gooding WE, El-Hefnawy T, Kelly L, Luketich JD, Godfrey TE. Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. Clin Chem. 2005 Jan; 51(1):113-8. PMID: 15539466

Lyons-Weiler J, Patel S, Becich MJ, Godfrey TE. Tests for finding complex patterns of differential expression in cancers: towards individualized medicine. BMC Bioinformatics. 2004 Aug 12; 5:110. PMID: 15307894; PMCID: PMC514539

Wang J, Xi L, Hunt JL, Gooding W, Whiteside TL, Chen Z, Godfrey TE, Ferris RL. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res. 2004 Mar 1; 64(5):1861-6. PMID: 14996750

El-Hefnawy T, Raja S, Kelly L, Bigbee WL, Kirkwood JM, Luketich JD, Godfrey TE. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem. 2004 Mar; 50(3):564-73. PMID: 14718398

Coello MC, Luketich JD, Litle VR, Godfrey TE. Prognostic significance of micrometastasis in non-small-cell lung cancer. Clin Lung Cancer. 2004 Jan; 5(4):214-25.View Related Profiles.

Godfrey, Tony
Litle, Virginia

PMID: 14967073

Makhija S, Sit A, Edwards R, Aufman K, Weiss H, Kanbour-Shakir A, Gooding W, D'Angelo G, Ferrell R, Raja S, Godfrey TE. Identification of genetic alterations related to chemoresistance in epithelial ovarian cancer. Gynecol Oncol. 2003 Jul; 90(1):3-9. PMID: 12821334

Raja S, Godfrey TE, Luketich JD. The role of tumor suppressor genes in esophageal cancer. Minerva Chir. 2002 Dec; 57(6):767-80. PMID: 12592219

Huang X, Gollin SM, Raja S, Godfrey TE. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A. 2002 Aug 20; 99(17):11369-74. PMID: 12172009; PMCID: PMC123263

Raja S, El-Hefnawy T, Kelly LA, Chestney ML, Luketich JD, Godfrey TE. Temperature-controlled primer limit for multiplexing of rapid, quantitative reverse transcription-PCR assays: application to intraoperative cancer diagnostics. Clin Chem. 2002 Aug; 48(8):1329-37. PMID: 12142391

Raja S, Luketich JD, Kelly LA, Gooding WE, Finkelstein SD, Godfrey TE. Rapid, quantitative reverse transcriptase-polymerase chain reaction: application to intraoperative molecular detection of occult metastases in esophageal cancer. J Thorac Cardiovasc Surg. 2002 Mar; 123(3):475-82; discussion 482-3. PMID: 11882818

Aldape K, Ginzinger DG, Godfrey TE. Real-time quantitative polymerase chain reaction: a potential tool for genetic analysis in neuropathology. Brain Pathol. 2002 Jan; 12(1):54-66. PMID: 11770902

Godfrey TE, Raja S, Finkelstein SD, Gooding WE, Kelly LA, Luketich JD. Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients. Clin Cancer Res. 2001 Dec; 7(12):4041-8. PMID: 11751499

Raja S, Finkelstein SD, Baksh FK, Gooding WE, Swalsky PA, Godfrey TE, Buenaventura PO, Luketich JD. Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett's esophagus. Ann Thorac Surg. 2001 Oct; 72(4):1130-5. PMID: 11603424

Simmons ML, Lamborn KR, Takahashi M, Chen P, Israel MA, Berger MS, Godfrey T, Nigro J, Prados M, Chang S, Barker FG, Aldape K. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res. 2001 Feb 1; 61(3):1122-8. PMID: 11221842

Ginzinger DG, Godfrey TE, Nigro J, Moore DH, Suzuki S, Pallavicini MG, Gray JW, Jensen RH. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res. 2000 Oct 1; 60(19):5405-9. PMID: 11034080

Raja S, Luketich JD, Kelly LA, Ruff DW, Godfrey TE. Increased sensitivity of one-tube, quantitative RT-PCR. Biotechniques. 2000 Oct; 29(4):702, 704, 706. PMID: 11056795

Suzuki S, Moore DH, Ginzinger DG, Godfrey TE, Barclay J, Powell B, Pinkel D, Zaloudek C, Lu K, Mills G, Berchuck A, Gray JW. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res. 2000 Oct 1; 60(19):5382-5. PMID: 11034075

Moore L, Godfrey T, Eng C, Smith A, Ho R, Waldman FM. Validation of fluorescent SSCP analysis for sensitive detection of p53 mutations. Biotechniques. 2000 May; 28(5):986-92. PMID: 10818706

Weiss WA, Godfrey T, Francisco C, Bishop JM. Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma. Cancer Res. 2000 May 1; 60(9):2483-7. PMID: 10811128

Godfrey TE, Kim SH, Chavira M, Ruff DW, Warren RS, Gray JW, Jensen RH. Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction. J Mol Diagn. 2000 May; 2(2):84-91. PMID: 11272893; PMCID: PMC1906896

Bastian BC, Kashani-Sabet M, Hamm H, Godfrey T, Moore DH, Bröcker EB, LeBoit PE, Pinkel D. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res. 2000 Apr 1; 60(7):1968-73. PMID: 10766187

Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet. 2000 Jan; 66(1):6-15. PMID: 10631132; PMCID: PMC1288349

Kim SH, Godfrey T, Jensen RH. Whole genome amplification and molecular genetic analysis of DNA from paraffin-embedded prostate adenocarcinoma tumor tissue. J Urol. 1999 Oct; 162(4):1512-8. PMID: 10492247

Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet. 1999 Jan; 21(1):99-102. PMID: 9916799

Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, Hwang SI, Polikoff D, Nonet G, Cochran J, Myambo K, Jay KE, Froula J, Cloutier T, Kuo WL, Yaswen P, Dairkee S, Giovanola J, Hutchinson GB, Isola J, Kallioniemi OP, Palazzolo M, Martin C, Ericsson C, Pinkel D, Albertson D, Li WB, Gray JW. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci U S A. 1998 Jul 21; 95(15):8703-8. PMID: 9671742; PMCID: PMC21140

Fejzo MS, Godfrey T, Chen C, Waldman F, Gray JW. Molecular cytogenetic analysis of consistent abnormalities at 8q12-q22 in breast cancer. Genes Chromosomes Cancer. 1998 Jun; 22(2):105-13. PMID: 9598797

Hiraguri S, Godfrey T, Nakamura H, Graff J, Collins C, Shayesteh L, Doggett N, Johnson K, Wheelock M, Herman J, Baylin S, Pinkel D, Gray J. Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res. 1998 May 1; 58(9):1972-7. PMID: 9581841

Godfrey TE, Cher ML, Chhabra V, Jensen RH. Allelic imbalance mapping of chromosome 16 shows two regions of common deletion in prostate adenocarcinoma. Cancer Genet Cytogenet. 1997 Oct 1; 98(1):36-42. PMID: 9309116

Godfrey TE, Ikebuchi M, Reynolds RJ, Hill CK. Characterization of a mammalian cell line that exhibits spontaneous and ultraviolet light-induced hypermutability while retaining resistance to cell killing by ultraviolet light. Int J Radiat Biol. 1995 Jun; 67(6):661-70. PMID: 7608629

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 85 publications over 24 distinct years, with a maximum of 11 publications in 2005